 |
| |
 |
APIs |
| |
|
Repaglinide |
| |
|
Sitagliptin phosphate |
| |
|
Imatinib Mesylate |
| |
|
Ezetimibe |
| |
|
Rivaroxaban |
| |
|
Pharmaceutical intermediates |
| |
|
Pyrophosphoric acid tetrabenzyl ... |
| |
|
1,3-Dichloro-1,1,3,3-tetraisopro... |
| |
|
2,5-Dihydroxy benzoic acid |
| |
|
2,4(1H,3H)-Pyrimidinedione, 5... |
| |
|
3,4-Dimethoxybenzoic acid |
| |
|
Custom-Production products |
| |
|
5,6-Diamino-2-picoline |
| |
|
2-Bromo-6-Acetylpyridine |
| |
|
2-Bromo-6-(2-methyl-1,3-dioxol... |
| |
|
6-Bromo-2-pyridinecarbonitrile |
| |
|
Material intermediate |
| |
|
Carbazole derivatives |
| |
|
Triphenylamine derivatives |
| |
|
Thiophene/Furan derivatives |
| |
|
Biphenyl derivatives |
|
 |
|
 |
4-[(4-methyl piperazine1-yl) methyl] benzoic acid dihydrochloride |
Product name: 4-[(4-methyl piperazine1-yl) methyl] benzoic acid dihydrochloride
CAS No.: 106261-49-8
Molecular formula: C16H13N5O2
Molecular weight: 307.3067
Assay: ≥99%
Molecular structure
|
|
|
